Traceability and Patient Safety

Dubai, UAE – January 30, 2025: In line with its vision to shape a future where every product is traceable and every supply chain is secure, EVOTEQ announced its partnership with DAF, the Egyptian company managing the implementation and operation of the Egyptian Drug Authority’s national track-and-trace system. This collaboration will bring a cutting-edge solution to Egypt, marking a pivotal step toward redefining medicine traceability, enhancing patient safety, combating counterfeit drugs and managing potential drug shortages.

The partnership was formalized through signing of a Memorandum of Understanding (MOU) in the presence of Dr Ahmed Afifi, CEO Egyptian Company for Medical Investment, on the third day of Arab Health 2025, at the Dubai World Trade Center. It strategically builds on EVOTEQ’s proven success in revolutionizing healthcare traceability in the UAE.